Susquehanna International Group, LLP Omega Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	SELL	$1.86 - $3.2 $61,566 - $105,920	-33,100 Reduced 59.64%	22,400 $46,000
Q1 2024 May 07, 2024	BUY	$2.73 - $5.32 $45,591 - $88,844	16,700 Added 43.04%	55,500 $202,000
Q4 2023 Feb 14, 2024	BUY	$1.35 - $3.21 $29,565 - $70,299	21,900 Added 129.59%	38,800 $116,000
Q3 2023 Nov 14, 2023	BUY	$2.15 - $5.68 $12,040 - $31,808	5,600 Added 49.56%	16,900 $36,000
Q2 2023 Aug 11, 2023	SELL	$5.6 - $9.66 $37,520 - $64,722	-6,700 Reduced 37.22%	11,300 $63,000
Q1 2023 May 16, 2023	SELL	$4.81 - $10.95 $74,074 - $168,630	-15,400 Reduced 46.11%	18,000 $108,000
Q4 2022 Feb 14, 2023	BUY	$4.22 - $7.05 $71,318 - $119,145	16,900 Added 102.42%	33,400 $190,000
Q3 2022 Nov 14, 2022	BUY	$3.63 - $6.65 $59,895 - $109,725	16,500 New	16,500 $89,000

43.4M

25.8K

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $35.9M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.